Showing results (11-20 of 18) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Mbio|January 17, 2019
Distinct Roles of Extracellular Domains in the Epstein-Barr Virus-Encoded BILF1 Receptor for Signaling and Major Histocompatibility Complex Class I DownregulationSuzan Fares, Katja Spiess, Emma T B Olesen, et al.Circulation|January 21, 2004
Cytomegalovirus infection impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine in transplant arteriosclerosisMichael Weis, Thomas N Kledal, Ken Y Lin, et al.The Journal of Biological Chemistry|March 17, 2006
Molecular pharmacological phenotyping of EBI2. An orphan seven-transmembrane receptor with constitutive activityMette M Rosenkilde, Tau Benned-Jensen, Helene Andersen, et al.Journal of Virology|April 15, 2011
Partial functional complementation between human and mouse cytomegalovirus chemokine receptor homologuesHelen E Farrell, Alexander M Abraham, Rhonda D Cardin, et al.Ugeskrift for Laeger|June 15, 2022
[The antiviral targeting potential of viroporins]John D Sund, Signe Bollerup, Jekob B Glamann, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 9, 2026
Targeting of Kaposi's sarcoma-associated herpesvirus by immunotoxins directed against the viral G protein-coupled receptor, ORF74Dagmar Fæster Kildedal, Anna Katarzyna Drzazga, Anjali Sharma, et al.Proceedings of the National Academy of Sciences of the United States of America|June 17, 2015
Rationally designed chemokine-based toxin targeting the viral G protein-coupled receptor US28 potently inhibits cytomegalovirus infection in vivoKatja Spiess, Mads G Jeppesen, Mikkel Malmgaard-Clausen, et al.The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 22, 2021
Ex vivo treatment of cytomegalovirus in human donor lungs using a novel chemokine-based immunotoxinRafaela V P Ribeiro, Terrance Ku, Aizhou Wang, et al.Pageof 2